1.Efficacy of Levamlodipine Besylate and Felodipine in the Treatment of Patients with Essential Hypertension
China Modern Doctor 2009;47(18):117-118,125
Objective To evaluate the efficacy and safety of ievamlodipine besylate and felodipine for patients with mild and moderate essential hypertension. Methods One hundred and four eases with essential hypertension were divided randomly into two groups:levamlodipine besylate group and felodipine group. Treatment lasted for 4 weeks. Parameters of blood pressure were measured before and after treatment. Results There was no significant difference in responder rates between patients taking levamlodipin besylate(84.62%) and patients taking felodipine(80.77%)(P>0.05). The untoward reaction in patients taking levamlodipine besylate(7.69%) was lower than that in patients taking felodipine(17.31%)(P < 0.05). Conclusion Levamlodipine besylate has effective at lowering blood pressure and light untoward reaction.
2.Experimental research of Pioglitazone on inhibiting intimal hyperplasia in vein grafts
Ludong LIANG ; Shikang LI ; Zhicun LAN ; Tianming HUO ; Qiangxin HUANG ; Jueyu ZHANG ; Jun PENG
Chinese Journal of Thoracic and Cardiovascular Surgery 2015;31(7):422-424
Objective To study the effect of Pioglitazone(PIO) on intimal hyperplasia after vein graft and its potential mechanism.Methods 32 male Sprague-Dawley rats were randomly divieded into two groups,one admisnistrated with PIO(3 mg· kg-1 · d-1) and the other with saline.A week later,the right common carotid arteries were reconstructed using homolateral external jugular veins in rats.The drugs treatment was continued after surgery for 2 or 4 weeks until grafted veins were harvested.The neointima thickness was measured by Computer image analysis software.To observe the activation of ERK1/2 pathway,the western blot were performed.In vitro,human great saphenous vein smooth muscle cells were co-cultured with PIO,and cells proliferation was detected by the CCK-8 assay.The TUNEL staining was performed to determine apoptosis.Results PIO treatment significantly attenuated intimal thickening compared with the the control group both at second [(8.56 ± 1.64) μm vs (25.44 ± 0.89) μm,P < 0.01] and fourth week [(10.51 ± 1.47) μm vs (35.69 ± 1.07) μm,P < 0.01)] after veins graft.Also PIO inhibited the ERK1/2 activation in grafted veins.In vitro,PIO significantly reduced PDGF-induced cells proliferation and increased cells apoptosis.Conclusion PIO effectively improved intimal hyperplasia in grafted veins perhaps associated with its ability to suppress vascular smooth muscle cells proliferation and enhance cell apoptosis,and might be related to the down regulation of ERK1/2 activity.
3.The impact of four metal ions on the phase behavior of phosphatidylcholine at the air/water interface.
Journal of Biomedical Engineering 2011;28(2):296-299
The impact of metal ions on the phase behavior of phosphatidylcholine (PC) was investigated at the air/water interface by surface pressure-area (pi-A) isotherm measurements. The analysis of the pi-A isotherms showed that with the metal ionic radius decreasing, the concentration of the metal ions C increasing, and the valence of metal ions Q increasing, the amount of the corresponding curves of A0 decreases, the phase transition point would change more apparently, the collapse pressure would become larger subsequently, and the curve would be extended outside. The phenomenon could be approached when the metal ion concentration C became great enough. These experiments were identified with the rules on Langmuir films, by a variety of properties of metal ions (ion radius, ion concentration, ion valence, etc.). Among all the factors, the ionic valence showed the greatest impact on the phase changes, followed by the ion concentration, while the ionic radius influences were less on the phase-change characteristics.
Air
;
Ions
;
chemistry
;
Membranes, Artificial
;
Metals
;
chemistry
;
Phase Transition
;
Phosphatidylcholines
;
chemistry
;
Surface Properties
;
Water
;
chemistry
4.Analysis of risk factors for clinical cure and biochemical recurrence in patients after radical prostatectomy
Yu FAN ; Yelin MULATI ; Lei LIANG ; Qinhan LI ; Zhenan ZHANG ; Binglei MA ; Quan ZHANG ; Zhicun LI ; Tianyu WU ; Yixiao LIU ; Cheng SHEN ; Qian ZHANG ; Wei YU ; Kai ZHANG ; Zhisong HE ; Liqun ZHOU
Chinese Journal of Urology 2021;42(9):644-649
Objective:To evaluate the risk factors of clinical cure and biochemical recurrence (BCR) after radical prostatectomy (RP).Methods:The clinical data of 896 patients who underwent RP at Peking University First Hospital from April 2001 to December 2020 were retrospectively analyzed. Average age was (65.90±6.3) years, median preoperative prostate specific antigen (PSA) was 10.75 (0.36-264.20) ng/ml, median prostate volume was 40.0 (12.0-220.9) ml, median PSA density (PSAD) was 0.27 (0.02-3.42) ng/(ml·g). Clinical staging: 432 cases in T 1c stage, 333 cases in T 2a/bstage, 76 cases in T 2c stage, and 55 cases in ≥T 3 stage. Preoperative Gleason score of biopsy: 193 cases in 3+ 3, 315 cases in 3+ 4, 162 cases in 4+ 3, 226 cases in ≥8. The RP surgery was operated by open or laparoscopic or robot-assisted approach. Clinical cure and BCR were used as the end points for analysis. Clinical cure was defined as a decrease in serum PSA level below 0.03 ng/ml 6 weeks after surgery. BCR was defined as the 2 consecutive serum PSA >0.2ng/ml during the follow-up after RP. Multivariate logistic regression was used to analyze the independent risk factors of clinical cure. The Kaplan-Meier method was used to draw the biochemical recurrence-free survival curve, the log-rank method was used for univariate analysis of BCR, and the Cox regression analysis was used for multivariate analysis. Results:All 896 patients were followed-up for 58 (5-241) months, 678 cases (75.7%) achieved clinical cure. Based on univariate analysis and multivariate analysis, among the preoperative indicators, whether the proportion of positive biopsy needles ≥33% ( P=0.007) and preoperative Gleason score of biopsy ( P=0.041) were independent risk factors of clinical cure. A total of 890 cases were included in the analysis of risk factors of BCR, of whom 172 cases (19.3%) had BCR. The 1-, 5-, and 10-year biochemical recurrence-free survival(BFS)rates were 98.1%, 83.1% and 68.4% respectively. The median BFS has not been reached, and the average BFS was 181 months (95% CI 172-189). The results of univariate and multivariate analysis showed that whether achieved clinical cure ( P=0.001) and postoperative pathological staging ( P<0.001) were independent risk factors of BCR. Conclusions:Whether the proportion of positive biopsy needles≥33% and preoperative Gleason score of biopsy were independent risk factors of clinical cure. Postoperative pathological staging and whether achieved clinical cure may be independent risk factors of BCR.